What Biotecnol Ltd. does

Biotecnol Ltd. is a private biopharmaceutical company headquartered in London, United Kingdom, that was founded in 2014 and operates with a headcount of 1–10 employees. The company's website (biotecnol.com) is the primary referenced digital presence, though the source data captured only a loader/verification page with no substantive product, pipeline, or corporate content.

No information on Biotecnol Ltd.'s specific therapeutic focus, drug pipeline, modality (e.g., biologics, small molecules, cell/gene therapy), platform technology, or development stage is present in the supplied data. There are no disclosed products, proprietary features, patents, trademarks, certifications, or partnerships in the input material. The management team, investor base, funding history, and ownership structure are likewise undocumented.

No revenue model, pricing mechanism, customer segments, or go-to-market motion is disclosed in the source data, which explicitly notes the absence of revenue information and the inability to determine operating status beyond a generic "operating" classification. As a result, the commercial mechanics of the business — how it generates income, whom it sells to, and through which channels — cannot be characterized from the available evidence.

Name

Biotecnol Ltd.

Legal name

Biotecnol Ltd.

Website

https://biotecnol.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Biotecnol Ltd. is a private, London-based biopharmaceutical company founded in 2014 with 1–10 employees. The source data contains no disclosed products, pipeline, customers, or revenue, leaving its specific therapeutic focus and commercial activity uncharacterized.

Ownership category

akta.pro rank

Product category

Biopharmaceuticals

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)

akta.pro primary industry

Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC)

akta.pro secondary industry

Biologic API/Drug Substance Manufacturing Services (HLAAAKAA)

Keywords

• Biopharmaceutical products
• Therapeutic development
• Drug development
• Pharmaceutical manufacturing
• Biologics production

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain

Core offering

Biotecnol Ltd. is a private biopharmaceutical company based in London, United Kingdom. Founded in 2014, it operates as a for-profit biopharmaceutical business; specific product, pipeline, or therapeutic area details are not available in the supplied source material.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Direct peers

• Abzena: UK-based biologics CDMO and developer offering development and manufacturing services for antibodies and biologics. Comparable to Biotecnol as a UK-rooted biopharmaceutical services and development player focused on therapeutic biologics.
• Crescendo Biologics: Cambridge, UK-based biopharma developing T cell-engaging antibody therapeutics. Comparable as a small UK-headquartered private biologics developer targeting similar customer/partner ecosystem.
• F-star Therapeutics: UK/EU biopharma developing bispecific antibody therapeutics. Comparable to Biotecnol as a private, European biologics developer focused on next-generation antibody platforms.
• Bicycle Therapeutics: UK-anchored biopharma developing bicyclic peptide-based therapeutics. Comparable as a UK-rooted private biologics developer with a proprietary platform targeting similar therapeutic and partnering opportunities.
• e-Therapeutics: UK-based biopharma leveraging computational and biological platforms for drug discovery. Comparable as a small UK private biopharma operating in biologics/small-molecule therapeutic R&D.

Broad incumbents

• Touchlight Genetics: UK-based CDMO specializing in enzymatic DNA production for cell/gene and biologic applications. Comparable to Biotecnol as a UK-rooted biologics-adjacent development and manufacturing services provider.
• Lonza: Global biologics CDMO providing cell-line development, drug substance and fill-finish services. Comparable as a leading incumbent in the same biologics manufacturing and development services category Biotecnol operates in.
• WuXi Biologics: Global end-to-end biologics CDMO offering discovery, development and manufacturing services. Comparable as a large incumbent in biologics services competing for the same outsourcing customers Biotecnol would serve.

Market position

Strengths2 records

Weaknesses3 records

Competitive moat1 record

Key risks4 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/biotecnol

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biotecnol Ltd.